Report Detail
Global (United States, European Union and China) Parkinsons Disease Drugs Market Research Report 2019-2025
- RnM3673319 |
- 16 August, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system.The symptoms generally come on slowly over time.Early in the disease, the most obvious are shaking, rigidity, slowness of movement, and difficulty with walking.Thinking and behavioral problems may also occur.Dementia becomes common in the advanced stages of the disease.Depression and anxiety are also common, occurring in more than a third of people with PD.Other symptoms include sensory, sleep, and emotional problems.The main motor symptoms are collectively called "parkinsonism", or a "parkinsonian syndrome"
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Parkinsons Disease Drugs in US$ by following Product Segments.: Clinical, Experiment
Company profiles are primarily based on public domain information including company
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
In 2019, the market size of Parkinsons Disease Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Parkinsons Disease Drugs.
This report studies the global market size of Parkinsons Disease Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Parkinsons Disease Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
Market Segment by Product Type
Clinical
Experiment
Market Segment by Application
Treament
Prevention
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Parkinsons Disease Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Parkinsons Disease Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Parkinsons Disease Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Parkinsons Disease Drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Clinical
- 1.3.3 Experiment
- 1.4 Market Segment by Application
- 1.4.1 Global Parkinsons Disease Drugs Market Share by Application (2019-2025)
- 1.4.2 Treament
- 1.4.3 Prevention
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Parkinsons Disease Drugs Market Size
- 2.1.1 Global Parkinsons Disease Drugs Revenue 2014-2025
- 2.1.2 Global Parkinsons Disease Drugs Sales 2014-2025
- 2.2 Parkinsons Disease Drugs Growth Rate by Regions
- 2.2.1 Global Parkinsons Disease Drugs Sales by Regions 2014-2019
- 2.2.2 Global Parkinsons Disease Drugs Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Parkinsons Disease Drugs Sales by Manufacturers
- 3.1.1 Parkinsons Disease Drugs Sales by Manufacturers 2014-2019
- 3.1.2 Parkinsons Disease Drugs Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Parkinsons Disease Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Parkinsons Disease Drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Parkinsons Disease Drugs Market Concentration Ratio (CR5 and HHI)
- 3.3 Parkinsons Disease Drugs Price by Manufacturers
- 3.4 Key Manufacturers Parkinsons Disease Drugs Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Parkinsons Disease Drugs Market
- 3.6 Key Manufacturers Parkinsons Disease Drugs Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Clinical Sales and Revenue (2014-2019)
- 4.1.2 Experiment Sales and Revenue (2014-2019)
- 4.2 Global Parkinsons Disease Drugs Sales Market Share by Type
- 4.3 Global Parkinsons Disease Drugs Revenue Market Share by Type
- 4.4 Parkinsons Disease Drugs Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Parkinsons Disease Drugs Sales by Application
6 United States
- 6.1 United States Parkinsons Disease Drugs Breakdown Data by Company
- 6.2 United States Parkinsons Disease Drugs Breakdown Data by Type
- 6.3 United States Parkinsons Disease Drugs Breakdown Data by Application
7 European Union
- 7.1 European Union Parkinsons Disease Drugs Breakdown Data by Company
- 7.2 European Union Parkinsons Disease Drugs Breakdown Data by Type
- 7.3 European Union Parkinsons Disease Drugs Breakdown Data by Application
8 China
- 8.1 China Parkinsons Disease Drugs Breakdown Data by Company
- 8.2 China Parkinsons Disease Drugs Breakdown Data by Type
- 8.3 China Parkinsons Disease Drugs Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Parkinsons Disease Drugs Breakdown Data by Company
- 9.2 Rest of World Parkinsons Disease Drugs Breakdown Data by Type
- 9.3 Rest of World Parkinsons Disease Drugs Breakdown Data by Application
- 9.4 Rest of World Parkinsons Disease Drugs Breakdown Data by Countries
- 9.4.1 Rest of World Parkinsons Disease Drugs Sales by Countries
- 9.4.2 Rest of World Parkinsons Disease Drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Johnson & Johnson
- 10.1.1 Johnson & Johnson Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Parkinsons Disease Drugs
- 10.1.4 Parkinsons Disease Drugs Product Introduction
- 10.1.5 Johnson & Johnson Recent Development
- 10.2 Gilead Sciences
- 10.2.1 Gilead Sciences Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Parkinsons Disease Drugs
- 10.2.4 Parkinsons Disease Drugs Product Introduction
- 10.2.5 Gilead Sciences Recent Development
- 10.3 Pacira
- 10.3.1 Pacira Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Parkinsons Disease Drugs
- 10.3.4 Parkinsons Disease Drugs Product Introduction
- 10.3.5 Pacira Recent Development
- 10.4 Sun Pharmaceutical
- 10.4.1 Sun Pharmaceutical Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Parkinsons Disease Drugs
- 10.4.4 Parkinsons Disease Drugs Product Introduction
- 10.4.5 Sun Pharmaceutical Recent Development
- 10.5 Luye Pharma
- 10.5.1 Luye Pharma Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Parkinsons Disease Drugs
- 10.5.4 Parkinsons Disease Drugs Product Introduction
- 10.5.5 Luye Pharma Recent Development
- 10.6 Sigma-Tau Group
- 10.6.1 Sigma-Tau Group Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Parkinsons Disease Drugs
- 10.6.4 Parkinsons Disease Drugs Product Introduction
- 10.6.5 Sigma-Tau Group Recent Development
- 10.7 Fudan-Zhangjiang
- 10.7.1 Fudan-Zhangjiang Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Parkinsons Disease Drugs
- 10.7.4 Parkinsons Disease Drugs Product Introduction
- 10.7.5 Fudan-Zhangjiang Recent Development
- 10.8 Teva Pharmaceutical
- 10.8.1 Teva Pharmaceutical Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Parkinsons Disease Drugs
- 10.8.4 Parkinsons Disease Drugs Product Introduction
- 10.8.5 Teva Pharmaceutical Recent Development
- 10.9 CSPC
- 10.9.1 CSPC Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Parkinsons Disease Drugs
- 10.9.4 Parkinsons Disease Drugs Product Introduction
- 10.9.5 CSPC Recent Development
- 10.10 Novartis
- 10.10.1 Novartis Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Parkinsons Disease Drugs
- 10.10.4 Parkinsons Disease Drugs Product Introduction
- 10.10.5 Novartis Recent Development
- 10.11 Kingond Pharm
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Parkinsons Disease Drugs Sales Channels
- 11.2.2 Parkinsons Disease Drugs Distributors
- 11.3 Parkinsons Disease Drugs Customers
12 Market Forecast
- 12.1 Global Parkinsons Disease Drugs Sales and Revenue Forecast 2019-2025
- 12.2 Global Parkinsons Disease Drugs Sales Forecast by Type
- 12.3 Global Parkinsons Disease Drugs Sales Forecast by Application
- 12.4 Parkinsons Disease Drugs Forecast by Regions
- 12.4.1 Global Parkinsons Disease Drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global Parkinsons Disease Drugs Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Parkinsons Disease Drugs. Industry analysis & Market Report on Parkinsons Disease Drugs is a syndicated market report, published as Global (United States, European Union and China) Parkinsons Disease Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Parkinsons Disease Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
